FDA approves Albiglutide [Tanzeum] to treat type 2 diabetes
April 16, 2014 – The U.S. Food and Drug Administration (FDA) yesterday approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects approximately 24 million people …
FDA approves Albiglutide [Tanzeum] to treat type 2 diabetes Read more »